Mayne Pharma Group Stock Forecast, Price & News

Mayne Pharma Group (OTCMKTS:MAYNF) Frequently Asked Questions

Is Mayne Pharma Group a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mayne Pharma Group in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Mayne Pharma Group stock.
View analyst ratings for Mayne Pharma Group or view top-rated stocks.

What stocks does MarketBeat like better than Mayne Pharma Group?

Wall Street analysts have given Mayne Pharma Group a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Mayne Pharma Group wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Mayne Pharma Group?

Mayne Pharma Group saw a decline in short interest during the month of September. As of September 30th, there was short interest totaling 1,041,500 shares, a decline of 27.9% from the September 15th total of 1,445,000 shares. Based on an average trading volume of 4,500 shares, the short-interest ratio is presently 231.4 days.
View Mayne Pharma Group's Short Interest.

How has Mayne Pharma Group's stock price been impacted by Coronavirus (COVID-19)?

Mayne Pharma Group's stock was trading at $0.1962 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, MAYNF stock has increased by 19.2% and is now trading at $0.2339.
View which stocks have been most impacted by COVID-19.

What price target have analysts set for MAYNF?

1 brokerages have issued 12-month price targets for Mayne Pharma Group's stock. Their forecasts range from $0.35 to $0.35. On average, they expect Mayne Pharma Group's stock price to reach $0.35 in the next year. This suggests a possible upside of 49.7% from the stock's current price.
View analysts' price targets for Mayne Pharma Group or view top-rated stocks among Wall Street analysts.

Who are Mayne Pharma Group's key executives?

Mayne Pharma Group's management team includes the following people:

• Scott Richards, Chief Executive Officer, MD & Executive Director
• Peter Paltoglou, Chief Financial Officer
• Keith Moore, Vice President-Research & Development
• Gerard G. Nahum, Chief Medical Officer
• Kate Hall, Executive Vice President & General Counsel

Who are some of Mayne Pharma Group's key competitors?

Some companies that are related to Mayne Pharma Group include Antisense Therapeutics (ANP), Bayer Aktiengesellschaft (BAYN), Mayne Pharma Group (MYX), Medical Developments International (MVP), Opthea (OPT), Otsuka (OTSKY), Patrys (PAB), Pharmaxis (PXS), Recce Pharmaceuticals (RCE), Roche (RHHVF), Sanofi (SNYNF), Sanofi (SAN), Sinclair Pharma (SPH) and Vita Life Sciences (VLS).
View all of MAYNF's competitors.

What is Mayne Pharma Group's stock symbol?

Mayne Pharma Group trades on the OTCMKTS under the ticker symbol "MAYNF."

How do I buy shares of Mayne Pharma Group?

Shares of MAYNF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Mayne Pharma Group's stock price today?

One share of MAYNF stock can currently be purchased for approximately $0.23.

How many employees does Mayne Pharma Group have?

Mayne Pharma Group employs 780 workers across the globe.

What is Mayne Pharma Group's official website?

The official website for Mayne Pharma Group is www.maynepharma.com.

Where are Mayne Pharma Group's headquarters?

Mayne Pharma Group is headquartered at 1538 Main North Road, Salisbury, South Australia.

How can I contact Mayne Pharma Group?

Mayne Pharma Group's mailing address is 1538 Main North Road, Salisbury, South Australia. The company can be reached via phone at (188) 209-2666.